February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Crapo: Republicans Stand Ready to Work on Meaningful Health Care Reform
- Crapo Statement at Social Security, USTR, HHS Nominations Hearing
- Crapo Announces Social Security, USTR, HHS Nominations Hearing
- Finance Committee Advances Treasury, IRS Nominations
- Crapo Statement at Executive Session to Consider Treasury, IRS Nominations